Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: potential role of tannins in cancer chemotherapy.

Tikoo K, Sane MS, Gupta C.

Toxicol Appl Pharmacol. 2011 Mar 15;251(3):191-200. doi: 10.1016/j.taap.2010.12.012. Epub 2010 Dec 29.

PMID:
21194538
2.

Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts.

Choi HJ, Seon MR, Lim SS, Kim JS, Chun HS, Park JH.

Exp Biol Med (Maywood). 2008 Dec;233(12):1554-60. doi: 10.3181/0807-RM-221. Epub 2008 Oct 10.

PMID:
18849542
3.

INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.

Mason KA, Valdecanas D, Hunter NR, Milas L.

Invest New Drugs. 2008 Feb;26(1):1-5. Epub 2007 Jul 13.

PMID:
17628743
4.

Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.

Li W, Xu B, Xu J, Wu XL.

Basic Clin Pharmacol Toxicol. 2009 Mar;104(3):192-7. doi: 10.1111/j.1742-7843.2008.00358.x. Epub 2009 Jan 8.

5.

Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27.

Turakhia S, Venkatakrishnan CD, Dunsmore K, Wong H, Kuppusamy P, Zweier JL, Ilangovan G.

Am J Physiol Heart Circ Physiol. 2007 Nov;293(5):H3111-21. Epub 2007 Sep 14.

6.

Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection.

Alfaro Y, Delgado G, Cárabez A, Anguiano B, Aceves C.

Mol Cancer. 2013 May 24;12:45. doi: 10.1186/1476-4598-12-45.

8.

Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts.

Evig CB, Kelley EE, Weydert CJ, Chu Y, Buettner GR, Burns CP.

Nitric Oxide. 2004 May;10(3):119-29.

PMID:
15158691
9.
10.

Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity.

Mitra MS, Donthamsetty S, White B, Latendresse JR, Mehendale HM.

Toxicol Appl Pharmacol. 2007 Nov 15;225(1):90-101. Epub 2007 Aug 21.

PMID:
17904602
11.

Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways.

Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B.

J Biol Chem. 2004 Jun 11;279(24):25535-43. Epub 2004 Mar 30.

12.

Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.

Ottewell PD, Mönkkönen H, Jones M, Lefley DV, Coleman RE, Holen I.

J Natl Cancer Inst. 2008 Aug 20;100(16):1167-78. doi: 10.1093/jnci/djn240. Epub 2008 Aug 11.

13.

Induction of caspase-independent apoptosis in H9c2 cardiomyocytes by adriamycin treatment.

Youn HJ, Kim HS, Jeon MH, Lee JH, Seo YJ, Lee YJ, Lee JH.

Mol Cell Biochem. 2005 Feb;270(1-2):13-9.

PMID:
15792349
14.

Prevention of doxorubicin induced cardiotoxicity by catechin.

Kozluca O, Olcay E, Sürücü S, Güran Z, Kulaksiz T, Uskent N.

Cancer Lett. 1996 Jan 19;99(1):1-6.

PMID:
8564920
15.

Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity.

Xin YF, Zhou GL, Shen M, Chen YX, Liu SP, Chen GC, Chen H, You ZQ, Xuan YX.

Basic Clin Pharmacol Toxicol. 2007 Dec;101(6):421-6. Epub 2007 Oct 25.

16.

Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells.

Du G, Lin H, Wang M, Zhang S, Wu X, Lu L, Ji L, Yu L.

Cancer Chemother Pharmacol. 2010 Jan;65(2):277-87. doi: 10.1007/s00280-009-1032-7.

PMID:
19466611
17.

Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.

Rokhlin OW, Glover RB, Guseva NV, Taghiyev AF, Kohlgraf KG, Cohen MB.

Mol Cancer Res. 2006 Feb;4(2):113-23.

18.

Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.

Li K, Sung RY, Huang WZ, Yang M, Pong NH, Lee SM, Chan WY, Zhao H, To MY, Fok TF, Li CK, Wong YO, Ng PC.

Circulation. 2006 May 9;113(18):2211-20. Epub 2006 May 1.

19.

HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest.

Venkatakrishnan CD, Dunsmore K, Wong H, Roy S, Sen CK, Wani A, Zweier JL, Ilangovan G.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1736-44. doi: 10.1152/ajpheart.91507.2007. Epub 2008 Feb 8.

20.

Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.

Aroui S, Brahim S, De Waard M, Bréard J, Kenani A.

Cancer Lett. 2009 Nov 18;285(1):28-38. doi: 10.1016/j.canlet.2009.04.044. Epub 2009 Jun 11.

PMID:
19523755
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk